JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 1, 2005; DOI: 10.1124/jpet.105.096255


0022-3565/06/3171-1-10$20.00
JPET 317:1-10, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.096255v1
317/1/1    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jajoo, S.
Right arrow Articles by Ramkumar, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jajoo, S.
Right arrow Articles by Ramkumar, V.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL

CELLULAR AND MOLECULAR

Induction of Adenosine A1 Receptor Expression by Pertussis Toxin via an Adenosine 5'-Diphosphate Ribosylation-Independent Pathway

Sarvesh Jajoo, Debashree Mukherjea, Sandeep Pingle, Yuko Sekino, and Vickram Ramkumar

Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois (S.J., D.M., V.R.); Department of Pharmacology, Georgetown University, Washington, DC (S.P.); and Gunma University School of Medicine, Maebashi, Japan (Y.S.)

Pertussis toxin ADP ribosylates Gi and Go transducing proteins and functionally uncouples adenosine A1 receptor (A1AR) from its effectors. We hypothesized that this loss in receptor coupling could lead to de novo A1AR synthesis by the cell in a futile attempt to re-establish normal receptor function. To test this hypothesis, we used hamster ductus deferens tumor (DDT1 MF-2) cells, a cell culture model for studying A1AR, and showed that pertussis toxin (100 ng/ml) produced a time-dependent loss in A1AR-Gi interaction and abolished A1AR activation of extracellular signal-regulated kinase 1/2. Interestingly, pertussis toxin increased the expression of A1AR, as measured by real-time polymerase chain reaction, immunocytochemistry, and [3H]cyclopentyl-1,3-dipropylxanthine (DPCPX) binding, suggesting a compensatory response to Gi protein inactivation. DDT1 MF-2 cells exposed to pertussis toxin demonstrated nuclear factor {kappa}B (NF-{kappa}B) activation within 30 min of exposure, a time point that preceded the loss of function of the A1AR. Inhibition of NF-{kappa}B attenuated the increase in A1AR induced by pertussis toxin. Cells exposed to B-oligomer subunit of pertussis toxin, devoid of significant ADP ribosyltransferase activity, showed increased A1AR protein expression, preceded by activation of NF-{kappa}B. B-Oligomer increased intracellular Ca2+ in DDT1 MF-2 cells. Chelation of intracellular Ca2+ with 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid or inhibition of protein kinase C (PKC) with bisindolylmaleimide hydrochloride reduced the activation of NF-{kappa}B and [3H]DPCPX binding. We conclude that pertussis toxin promotes de novo A1AR synthesis by activating NF-{kappa}B through an ADP ribosylation-independent mechanism involving intracellular Ca2+ release and PKC activation.


Received September 26, 2005; accepted November 30, 2005.

Address correspondence to: Dr. Vickram Ramkumar, Southern Illinois University School of Medicine, P.O. Box 19629, Springfield, IL 62794-9629. E-mail: vramkumar{at}siumed.edu




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
I. Zanotti, F. Poti, M. Pedrelli, E. Favari, E. Moleri, G. Franceschini, L. Calabresi, and F. Bernini
The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential
J. Lipid Res., May 1, 2008; 49(5): 954 - 960.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. C. Pingle, S. Jajoo, D. Mukherjea, L. F. Sniderhan, K. A. Jhaveri, A. Marcuzzi, L. P. Rybak, S. B. Maggirwar, and V. Ramkumar
Activation of the Adenosine A1 Receptor Inhibits HIV-1 Tat-Induced Apoptosis by Reducing Nuclear Factor-{kappa}B Activation and Inducible Nitric-Oxide Synthase
Mol. Pharmacol., October 1, 2007; 72(4): 856 - 867.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. G. Baker and S. J. Hill
A Comparison of the Antagonist Affinities for the Gi- and Gs-Coupled States of the Human Adenosine A1-Receptor
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 218 - 228.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. R. Lenard, V. Prpic, A. W. Adamson, R. C. Rogers, and T. W. Gettys
Differential coupling of beta3A- and beta3B-adrenergic receptors to endogenous and chimeric G{alpha}s and G{alpha}i
Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E704 - E715.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Iqbal, K. Kumar, L. Sun, and M. Zaidi
Selective upregulation of the ADP-ribosyl cyclases CD38 and CD157 by TNF but not by RANK-L reveals differences in downstream signaling
Am J Physiol Renal Physiol, September 1, 2006; 291(3): F557 - F566.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.